Global Radiation Therapy Systems Market, March 2016

This report covers the large, highly competitive, technology driven Global Market for Radiation Therapy Systems—valued at nearly $4.3 billion in 2015.

Radiation therapy, sometimes called radiotherapy, uses various types of specialized, focused energy to kill cancer cells and shrink tumors, and is commonly used either alone or in combination with surgery or chemotherapy. Radiation therapy is being used to treat a broad and growing number of cancers, and offers a variety of specialized treatments according to the type of tumor, as well as the size and location. Major factors driving the growth in radiation therapy is its nonsurgical technique and efficacy (it is believed that the majority, or approximately 50-60% of cancer patients undergo radiation therapy during the course of treatment).

Despite significant competition and continued pricing pressures, the Global Radiation Therapy Systems market will benefit from pent-up demand addressing the linac shortage and is also expected to benefit from an expected growth in healthcare expenditures mid-term (in the US as well as in selected countries in the ROW), after a lengthy, challenging global economic period that resulted in significant hospital budgetary restraints. Services and aftermarket sales are expected to grow from the installed base at a faster pace over the next 5 years, resulting in an overall mid-single-digit growth rate for the US, ROW (particularly in emerging markets) and for the combined global market. Due to the fact that there is a significant shortage of linacs and other radiation therapy equipment worldwide, amidst ever-growing cancer rates, annual growth exceeding 5-6% is quite feasible over the forecast period and beyond.

This dynamic, new report from Medtech Insight includes a profile of dozens of selected leading, new or emerging products/technologies expected to enhance radiation therapy; a comprehensive Global Radiation Therapy Systems market analysis, including expected market forecasts (from 2014-2019) and segment growth for the US and ROW; market drivers/limiters; competitive analysis, including 2015 market share by supplier (for US, ROW, Global), and corporate strategies. This report covers external beam radiation therapy (EBRT) and internal radiation therapy, specifically: linacs/radiosurgery systems, brachytherapy equipment/accessories, services and treatment planning software. Additionally, emerging proton therapy, high-definition radiotherapy (HDRT), and new MRI-based radiation systems also discussed, which may potentially revolutionize radiation therapy, providing more efficient treatment to expanded patient populations with greater efficacy, faster treatment times, and greater sparing of healthy tissue.